Biobetter biotechs emerge as preclinical services clients
Biotechs set up to take an existing biologic, improve it and license the resulting biobetter are an emerging client for preclinical service providers.
Biotechs set up to take an existing biologic, improve it and license the resulting biobetter are an emerging client for preclinical service providers.
Primary packaging maker Schott has joined the growing list of drug industry companies seeking to tap Russian government demand for increased domestic manufacturing.
Indian regulators plan to standardise clinical trial serious adverse event (SAE) reporting to ensure complete data is submitted.
update
Indian CRO GVK Biosciences has been named as a preferred provider by a consortium, Product Development Partners (PDP), which is focused on drugs for neglected diseases.
Work towards manufacturing scale-up of a smallpox antiviral has been suspended after a protest was filed against award of the US government contract.
Californian Bioreactor manufacturer, PBS Biotech, has launched its new PBS 3 single-use bioreactor system for the development of biological therapeutics, vaccines and biosimilars.